Titan Pharmaceuticals
TTNP
3,48 €
Share price
-8.22%
Change (1 day)
-33.97%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €0.24 Million
According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are €0.24 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | €1.3 M | -48.01% |
| 2022-12-31 | €2.51 M | -0.37% |
| 2021-12-31 | €2.52 M | -31.9% |
| 2020-12-31 | €3.7 M | -48.71% |
| 2019-12-31 | €7.22 M | 13.72% |
| 2018-12-31 | €6.34 M | -5.33% |
| 2017-12-31 | €6.7 M | 28.84% |
| 2016-12-31 | €5.2 M | -9.6% |
| 2015-12-31 | €5.75 M | -42.78% |
| 2014-12-31 | €10.06 M | 9.76% |
| 2013-12-31 | €9.16 M | -74.71% |
| 2012-12-31 | €36.25 M | 55.4% |
| 2011-12-31 | €23.32 M | 187.18% |
| 2010-12-31 | €8.12 M | 195.91% |
| 2009-12-31 | €2.74 M | |
| 2007-12-31 | €2.91 M | 13.32% |
| 2006-12-31 | €2.57 M | -2.84% |
| 2005-12-31 | €2.64 M | -2.2% |
| 2004-12-31 | €2.7 M | 2.01% |
| 2003-12-31 | €2.65 M | -29.68% |
| 2002-12-31 | €3.77 M | -42.18% |
| 2001-12-31 | €6.52 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Vanda Pharmaceuticals VNDA | €0.10 B | 43,096.77% | 🇺🇸 USA |
 MediciNova MNOV | €2.16 M | 796.30% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | €31.58 M | 12,978.85% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €100.03 B | 41,419,971.68% | 🇺🇸 USA |
 Novartis NVS | €53.22 B | 22,038,968.10% | 🇨🇭 Switzerland |
 Repligen
RGEN | €0.75 B | 310,530.82% | 🇺🇸 USA |